Search research articles
Contact Us
Filters
Showing results (121-130 of 141) with videos related to
Page
of 15
Sort By:
Transplantation and Cellular Therapy
|
September 19, 2021
Bone Marrow versus Peripheral Blood Grafts for Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide
Rohtesh S Mehta, Rima M Saliba, Leonard C Alsfeld, et al.
The Lancet. Haematology
|
November 4, 2018
Fludarabine with a higher versus lower dose of myeloablative timed-sequential busulfan in older patients and patients with comorbidities: an open-label, non-stratified, randomised phase 2 trial
Uday R Popat, Rohtesh S Mehta, Roland Bassett, et al.
British Journal of Haematology
|
September 22, 2025
Allogeneic haematopoietic cell transplantation in advanced systemic mastocytosis in the new era: A CIBMTR study
Celalettin Ustun, Mei-Jie Zhang, Andrew Peterson, et al.
Transplantation and Cellular Therapy
|
September 23, 2020
Hematopoietic Cell Transplantation in the Treatment of Newly Diagnosed Adult Acute Myeloid Leukemia: An Evidence-Based Review from the American Society of Transplantation and Cellular Therapy
Bhagirathbhai Dholaria, Bipin N Savani, Betty K Hamilton, et al.
The New England Journal of Medicine
|
December 14, 2012
Cord-blood engraftment with ex vivo mesenchymal-cell coculture
Marcos de Lima, Ian McNiece, Simon N Robinson, et al.
Transplantation and Cellular Therapy
|
June 12, 2026
Randomized trial of two fractionation schedules of myeloablative busulfan with fludarabine and cladribine in AML or MDS
Uday R Popat, Konstantinos Lontos, Roland Bassett, et al.
Cytotherapy
|
December 15, 2025
Ex vivo mesenchymal progenitor cell-based cord blood cell expansion and exofucosylation to enhance transplant engraftment
Portia Smallbone, Mayela Mendt, Robert Sackstein, et al.
Blood Cancer Journal
|
March 28, 2026
Impact of allogeneic stem cell transplantation in patients with higher risk myelodysplastic syndromes
Alexandre Bazinet, Alex Bataller, Kelly Chien, et al.
Blood
|
March 18, 2015
Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation
Uday Popat, Rohtesh S Mehta, Katayoun Rezvani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 30, 2021
Third-Party BK Virus-Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following Allotransplantation
Amanda Olson, Ruitao Lin, David Marin, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 141) with videos related to
Sort By:
Page
of 15
Transplantation and Cellular Therapy
|
September 19, 2021
Bone Marrow versus Peripheral Blood Grafts for Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide
Rohtesh S Mehta, Rima M Saliba, Leonard C Alsfeld, et al.
The Lancet. Haematology
|
November 4, 2018
Fludarabine with a higher versus lower dose of myeloablative timed-sequential busulfan in older patients and patients with comorbidities: an open-label, non-stratified, randomised phase 2 trial
Uday R Popat, Rohtesh S Mehta, Roland Bassett, et al.
British Journal of Haematology
|
September 22, 2025
Allogeneic haematopoietic cell transplantation in advanced systemic mastocytosis in the new era: A CIBMTR study
Celalettin Ustun, Mei-Jie Zhang, Andrew Peterson, et al.
Transplantation and Cellular Therapy
|
September 23, 2020
Hematopoietic Cell Transplantation in the Treatment of Newly Diagnosed Adult Acute Myeloid Leukemia: An Evidence-Based Review from the American Society of Transplantation and Cellular Therapy
Bhagirathbhai Dholaria, Bipin N Savani, Betty K Hamilton, et al.
The New England Journal of Medicine
|
December 14, 2012
Cord-blood engraftment with ex vivo mesenchymal-cell coculture
Marcos de Lima, Ian McNiece, Simon N Robinson, et al.
Transplantation and Cellular Therapy
|
June 12, 2026
Randomized trial of two fractionation schedules of myeloablative busulfan with fludarabine and cladribine in AML or MDS
Uday R Popat, Konstantinos Lontos, Roland Bassett, et al.
Cytotherapy
|
December 15, 2025
Ex vivo mesenchymal progenitor cell-based cord blood cell expansion and exofucosylation to enhance transplant engraftment
Portia Smallbone, Mayela Mendt, Robert Sackstein, et al.
Blood Cancer Journal
|
March 28, 2026
Impact of allogeneic stem cell transplantation in patients with higher risk myelodysplastic syndromes
Alexandre Bazinet, Alex Bataller, Kelly Chien, et al.
Blood
|
March 18, 2015
Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation
Uday Popat, Rohtesh S Mehta, Katayoun Rezvani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 30, 2021
Third-Party BK Virus-Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following Allotransplantation
Amanda Olson, Ruitao Lin, David Marin, et al.
Page
of 15